Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
According to Novo Nordisk's latest financial reports the company has $14.31 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $15.78 B | 31.27% |
2022-12-31 | $12.02 B | 11.62% |
2021-12-31 | $10.77 B | 2.9% |
2020-12-31 | $10.46 B | 21.22% |
2019-12-31 | $8.63 B | 8.72% |
2018-12-31 | $7.94 B | -1.1% |
2017-12-31 | $8.03 B | 25.29% |
2016-12-31 | $6.40 B | -6.88% |
2015-12-31 | $6.88 B | 4.59% |
2014-12-31 | $6.58 B | -16.5% |
2013-12-31 | $7.88 B | 9.39% |
2012-12-31 | $7.20 B | 10.44% |
2011-12-31 | $6.52 B | -1.11% |
2010-12-31 | $6.59 B | -4.16% |
2009-12-31 | $6.88 B | 10.89% |
2008-12-31 | $6.20 B | -1.56% |
2007-12-31 | $6.30 B | 18.04% |
2006-12-31 | $5.34 B | 22.28% |
2005-12-31 | $4.36 B | -10.07% |
2004-12-31 | $4.85 B | 13.56% |
2003-12-31 | $4.27 B | 29.49% |
2002-12-31 | $3.30 B | 14.01% |
2001-12-31 | $2.89 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $89.28 B | 523.80% | ๐บ๐ธ USA |
Eli Lilly LLY | $12.89 B | -9.89% | ๐บ๐ธ USA |
Sanofi SNY | $82.20 B | 474.30% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $16.54 B | 15.61% | ๐บ๐ธ USA |